Genomed Spólka Akcyjna reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was PLN 22.48 million compared to PLN 20.46 million a year ago. Net income was PLN 0.991503 million compared to PLN 0.337956 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28 PLN | 0.00% | 0.00% | -6.04% |
1st Jan change | Capi. | |
---|---|---|
-6.04% | 9.18M | |
+49.21% | 56.95B | |
+39.98% | 40.26B | |
-6.86% | 39.32B | |
-4.42% | 28.37B | |
+12.00% | 26.45B | |
-18.27% | 19.41B | |
+29.57% | 12.54B | |
+25.41% | 12.21B | |
-0.35% | 12.15B |
- Stock Market
- Equities
- GEN Stock
- News Genomed Spólka Akcyjna
- Genomed Spólka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2023